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Abstract
Introduction: Nocardia cyriacigeorgica bacteraemia has been described in the setting of profound
immunodeficiency in only two previous case reports. In both instances, diagnosis was rapidly facilitated by 16S
rRNA gene sequencing of blood culture isolates. To the best of our knowledge, we believe that our case is the first
presentation of N. cyriacigeorgica bacteraemia associated with acute cytomegalovirus disease in a kidney transplant
recipient, which was then followed by severe and fatal pneumonia only seven days later.
Case presentation: We present the case of a 73-year-old Caucasian woman, a renal transplant recipient, with
peripheral vascular disease, hypertension, osteoporosis and vascular dementia who was diagnosed with septicemia
and pneumonia. In spite of appropriate anti-microbial therapy for nocardial sepsis, she developed severe
pneumonia and acute renal failure.
Conclusion: This case illustrates a potential for disseminated nocardial infection to produce clinical syndromes that
may be indistinguishable from acute cytomegalovirus disease. An atypical presentation (pneumonia and renal
failure) of a rare disease (nocardial septicemia) in the setting of renal transplantation is discussed. This case
illustrates that the possibility of severe cytomegalovirus disease should be considered in renal transplanted patients
diagnosed with nocardial septicemia who subsequently develop severe sepsis, pneumonia, and renal failure.
Molecular diagnosis should readily be available to assist with the prompt diagnosis and treatment of these
infections in renal transplant patients.
Introduction
Nocardia cyriacigeorgica bacteraemia has been described
in the setting of profound immunodeficiency in only
two previous case reports [1,2]. Our case is unusual due
to its co-existence with cytomegalovirus (CMV) disease,
renal transplantation, and acute rapidity and severity of
the subsequent fatal pneumonia. Although there is a
link between nocardial septicemia and various medical
conditions, its association with acute CMV disease in
this setting remains elusive [3,4]. Disseminated nocar-
diosis and acute CMV disease are known to induce an
assemblage of clinical syndromes which are non-specific,
requiring rapid, sensitive and specific microbiological
techniques to delineate one from the other. In summary,
w ed e s c r i b ean o v e la n dh i g h l yu n u s u a lc a s ei nw h i c h
the diagnosis of nocardial septicemia co-existed with
acute CMV disease only diagnosed after death.
Case Presentation
Our patient was a 73-year-old Caucasian woman with a
transplanted kidney, peripheral vascular disease, hyper-
tension, osteoporosis and vascular dementia who pre-
sented to our hospital with a 10-day history of non-
productive cough, vomiting, anorexia, and fever and was
non-specifically unwell. The family doctor had recently
treated her with trimethoprim for a urinary tract infec-
tion. She had received a kidney transplant from her sis-
ter 11 years previously due to polycystic kidney disease
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cyclosporine (75 mg twice daily) and prednisolone (7.5
mg once daily).
On examination, our patient was confused, restless
and pyrexial with a temperature of 38.4ˌC, respiration
rate of 24 breaths/min, blood pressure 111/72 mmHg,
and reduced air entry to both lung bases. An echocar-
diogram showed sinus tachycardia of 129 beats/min. She
appeared cachexic and dehydrated. Hematological and
biochemical investigations revealed hemoglobin 9.7 g/dl,
white cell count 16.0 × 10
9/L (neutrophils 14.4 × 10
9
/L), sodium 136 mmol/L, potassium 5.8 mmol/L, urea
49.7 mmol/L, creatinine 447 μmol/L, bilirubin 18 μmol/
L, alanine aminotransferase 60i u/L, alkaline phospha-
tase 92i u/L, total protein 60 g/L, albumin 25 g/L, and
C-reactive protein (CRP) 315 mg/L. A clotted blood
sample and ethylene-diamine-tetra-acetic acid (EDTA)
whole blood sample for CMV quantitative polymerase
chain reaction (PCR) were obtained on the day of death.
The clotted sample was positive for CMV immunoglo-
bulin M (IgM) antibodies but negative for CMV immu-
noglobulin G (IgG) antibodies, and the EDTA blood
sample for CMV PCR yielded 11, 899 copies/mL consis-
tent with active CMV disease at the limit of sensitivity
of the test at 500 copies/mL.
A chest X-ray revealed a right lower lobe infiltrate and
severe kyphoscoliosis. An arterial blood gases analysis
on air showed pH 7.424, partial carbon dioxide (pCO2)
3.31 kPa, partial oxygen (pO2) 32.16 kPa, saturation of
peripheral oxygen (SpO2) 99.6% and base excess (BE)
-6.5 mmol/L. A clinical diagnosis of community-
acquired pneumonia was made and given a CURB-65
score of 3/5, giving a prediction of 17% risk of death.
Our patient was known to be mildly allergic to penicillin
and was therefore started on empirical intravenous anti-
biotics with imipenem 500 mg every 12 hours to treat
possible multiply-resistant Gram-negative bacilli asso-
ciated with urosepsis, and 1000 mL of sodium chloride
intravenous infusion 0.9% was given over eight hours
and repeated as appropriate to correct dehydration.
Although she remained apyrexial with normal hemody-
namic variables for a few more days, her inflammatory
markers remained markedly raised and renal function
continued to deteriorate gradually despite antibiotics,
intravenous fluids and renal support.
On admission to hospital, one set of BacT/ALERT 3D
(bioMérieux, Inc., Durham, North Carolina, USA) aero-
bic and anaerobic blood cultures were collected. After
four days of incubation, the aerobic bottle demonstrated
long thin Gram positive rod shaped bacterium, identi-
fied as Nocardia species, sensitive to doxycycline and
imipenem, resistant to penicillin, erythromycin, tri-
methoprim, levofloxacin, clindamycin, rifampicin, teico-
planin and vancomycin based on British Society for
Antimicrobial Chemotherapy (BSAC) disk diffusion
susceptibility testing. A diagnosis of disseminated nocar-
diosis was subsequently made and imipenem was
continued.
Our patient’s clinical condition deteriorated rapidly on
day six, developing severe acidotic breathing, reduced
level of consciousness (Glasgow Coma Scale 3/15) and
acute oliguria, despite adequate fluid resuscitation.
Arterial blood gases analysis on 2 L of oxygen showed
pH 7.121, pCO2 8.41 kPa, pO2 8.77 kPa, SpO2 85.3.6%
and BE -10.1 mmol/L. Hematological and biochemical
investigations revealed hemoglobin 6.8 g/dL, white cell
count 10.7 × 10
9/L (neutrophils 9.8.4 × 10
9 /L), sodium
136 mmol/L, potassium 5.4 mmol/L, urea 43.5 mmol/L,
creatinine 312 μmol/L, bilirubin 6 μmol/L, alkaline
phosphatase 83i u/L, total protein 40 g/L, albumin 14 g/
L, and CRP 178 mg/L. A chest physician consultation
confirmed that our patient was in severe respiratory fail-
ure and had severe pneumonia, but was unlikely to ben-
efit from the use of high dose co-trimoxazole and/or
valganciclovir respectively to cover for possible Pneumo-
cystis jirovecii or CMV infection, and critical care sup-
port and assisted ventilation. The patient died on day
seven after admission, and her family requested that an
autopsy not be performed.
The blood culture isolate was confirmed as N. cyriaci-
georgica at the Molecular Identification Services Unit,
Centre for Infections, Health Protection Agency, Lon-
don, by using partial sequencing of the 16S rDNA and
cluster analysis of the gyraseB gene (Figure 1).
Discussion
The incidence of nocardial infections is believed to be
on the rise worldwide as a result of a growing immune-
compromised population and improved methods for
pathogen isolation and molecular identification [5].
Disseminated nocardiosis is frequently characterized
by pulmonary involvement in over 68% of patients,
while isolation of the organism, and particularly N.
cyriageorgica, from blood is very rare [6] even in the
presence of severe immune-suppression, cancer and
transplantation [2]. These observations have generally
remained unexplained in the literature, although it has
been suggested that if nocardia infection is clinically
suspected, then efforts to optimize the recovery of the
micro-organisms in a Bactec blood culture system
should be used, with prolonged incubation beyond the
usual five days and with frequent and terminal sub-
culturing [5]. In the present case, blood cultures incu-
bated in a Bactec blood culture system yielded growth
in four days, but unfortunately a sputum sample was
not obtained to confirm presence of Nocardia in her
lung as right lower lobe infiltrate was identified with
radiology.
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have been recently described, including N. cyriacigeor-
gica [7,8]. This species has been rarely reported and
overlooked in human infections so far, since molecular
techniques for species identification have not been avail-
able [9]. Thus, the present isolate was initially identified
only as Nocardia species by the API system.
Our patient was treated with intravenous imipenem
to which the isolate was sensitive but there was no
clinical improvement noted. Until now, no study has
established a correlation between the results obtained
in vitro and the clinical outcome of the patients under
treatment with imipenem [10]. Previous studies have
suggested clinical response of patients treated with co-
trimoxazole was higher than those treated with other
antibiotics [6].
In a recent prospective study of 471 consecutive renal
transplant recipients, both asymptomatic CMV infection
and CMV disease were identified as independent risk
factors for overall mortality beyond 100 days post-trans-
plantation [11]. Our patient presented with fever, anor-
exia, vomiting, coughing, lymphopenia and elevated liver
enzymes, symptoms consistent with CMV disease as
confirmed by significantly elevated CMV viral load at
diagnosis [12]. It is debatable whether our patient could
have benefited from early prophylaxis and treatment
with ganciclovir if CMV PCR results were known in the
early stages of her disease [12].
Although the association of bacteraemic nocardiosis
with systemic steroids are described, to the best of our
knowledge this is the first case in which nocardiosis is
linked to acute CMV disease. There are conflicting
reports on whether or not the intensity of immune-sup-
pression in kidney transplant recipients is associated
with the risk of CMV infections [11] and therefore
further studies are needed to identify any risk factors for
CMV infections in kidney transplant recipients to enable
prevention strategies for CMV infection to be
reconsidered.
Conclusion
N. cyriacigeorgica septicemia and pneumonia in a kidney
transplant recipient, co-existing with CMV disease, is
rarely reported and may be difficult to diagnose with
traditional microbiological methods. New molecular typ-
ing schemes are now available to identify new species
and assist with the management of patients with inva-
sive disease. Co-existing CMV disease and infections
should be diagnosed promptly with CMV PCR to assist
with the early treatment and/or prophylaxis with valgan-
ciclovir. This case contributes to the spectrum of dis-
eases that may be seen in immune-suppressed patients
after kidney transplantation.
Consent
Written informed consent was obtained from the
patient’s next-of-kin for publication of this case report
and any accompanying images. A copy of the written
consent is available for review by the Editor-in-Chief of
this journal.
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Figure 1 The tree shows the clustering of Nocardia species based on the similarity of their gyrB gene sequences.T h es c a l eb a ri sa
measure of the evolutionary distance between species based on the length of the branches. Case Report isolate of N. cyriageorgica is number
0676.
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